Abstract
Bayer MaterialScience (BMS) is bringing its work on carbon nanotubes (CNTs) to a close due to a perceived lack of application opportunities in areas linked to its core business. According to BMS CEO Patrick Thomas, ground-breaking applications for the mass market relating to its own portfolio and therefore comprehensive commercialization ‘are not likely in the foreseeable future’. BMS says it has not yet determined precisely how its research results and know-how for the production and application of CNTs will be used further.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
